NCT05099432

Brief Summary

Colonoscopic removal of polyps is an important and well-established tool in the prevention of colorectal cancers. However, high polyp recurrence rates after endoscopic resection, with resultant development of interval cancers, remains a problem; this most commonly stems from unrecognised incomplete polyp resection. Thus, a standardised endoscopic technique is needed that will allow endoscopists to consistently achieve a clear margin of resection. The investigators believe the Cap Assisted Resection Margin Assessment (CARMA) technique will address this problem. This novel technique focuses on a standardised assessment of the resection margin after endoscopic polypectomy utilising available standard high-definition video endoscopes with imaging features including narrow band imaging (NBI) and magnification endoscopy.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
6mo left

Started Nov 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
Nov 2021Nov 2026

First Submitted

Initial submission to the registry

October 18, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

October 29, 2021

Completed
3 days until next milestone

Study Start

First participant enrolled

November 1, 2021

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2023

Completed
3.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2026

Expected
Last Updated

November 15, 2021

Status Verified

November 1, 2021

Enrollment Period

1.5 years

First QC Date

October 18, 2021

Last Update Submit

November 5, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Rate of achieving a clear resection margin using the CARMA technique

    Established during index procedure

Secondary Outcomes (11)

  • Sensitivity and specificity of the CARMA technique for residual polyp detection

    Established during index procedure

  • Frequency of residual polyp without CARMA assessment

    Established during index procedure

  • Incomplete resection rate with use of CARMA technique

    Established during index procedure

  • Incomplete resection rate with use of the CARMA technique in polyps > 10mm with hot snare

    Established during index procedure

  • Incomplete resection rate with use of the CARMA technique in polyps > 10mm with cold snare

    Established during index procedure

  • +6 more secondary outcomes

Study Arms (1)

CARMA Technique

EXPERIMENTAL

All included participants undergo polyp resection using standard of care polypectomy techniques, followed by the CARMA technique

Procedure: CARMA technique

Interventions

Once standard polyp resection and assessment of the polypectomy site without magnification is completed, the CARMA technique will be applied. This will involve an assessment of the entire polypectomy margin using cap assisted magnification endoscopy with the ability to also use NBI (at the endoscopist's discretion) and documentation of any residual polyp noted.

CARMA Technique

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • \- any polypectomy (though only a maximum of two polyps from one individual participant)

You may not qualify if:

  • polyps less than 10mm which were resected under endoscopic view with a definite \> 1mm clear margin
  • scar site recurrence polyps
  • polyps with endoscopic evidence of invasion
  • pedunculated polyps
  • pseudopolyps
  • participants who will not be available for follow up endoscopy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Princess Alexandra Hospital

Woolloongabba, Queensland, 4102, Australia

RECRUITING

MeSH Terms

Conditions

Colonic Polyps

Condition Hierarchy (Ancestors)

Intestinal PolypsPolypsPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Alexander Huelsen, MD

    Princess Alexandra Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Interventional Gastroenterologist, Principal Investigator

Study Record Dates

First Submitted

October 18, 2021

First Posted

October 29, 2021

Study Start

November 1, 2021

Primary Completion

May 1, 2023

Study Completion (Estimated)

November 1, 2026

Last Updated

November 15, 2021

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will not share

Locations